The effect of lifestyle and risk factor modification on occlusive peripheral arterial disease outcomes: standard healthcare vs structured programme—for a randomised controlled trial protocol

Abstract Background Peripheral arterial disease (PAD) affects more than 200 million of the global population. PAD represents a marker for premature cardiovascular events. Patients with PAD, even in the absence of a history of myocardial infarction or ischemic stroke, have approximately the same rela...

Full description

Bibliographic Details
Main Authors: M. Elfghi, F. Jordan, D. Dunne, I. Gibson, J. Jones, G. Flaherty, S. Sultan, W. Tawfick
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Trials
Subjects:
Online Access:https://doi.org/10.1186/s13063-021-05087-x